Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-controlled Comparability Study to Compare Two Presentations of CagriSema in Participants With Overweight or Obesity

NCT07357766 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07357766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07357766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-controlled Comparability Study to Compare Two Presentations of CagriSema in Participants With Overweight or Obesity
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Withdrawn
Start date
June 22, 2026
Completion date
January 17, 2028
Enrollment
0 (actual)
Sites
116

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight